The concomitant use of proton pump inhibitors and BRAF/MEK inhibitors in metastatic melanoma.
The British journal of dermatology(2023)
摘要
In a population-based cohort of patients with advanced melanoma, the concomitant use of PPIs and BRAF/MEK inhibitors was not associated with worse outcome.
更多查看译文
关键词
braf/mek inhibitors,proton pump inhibitors,melanoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要